Farrukh Aqil Selected Research

ErbB Receptors (EGF Receptor)

5/2011

Promising molecular targeted therapies in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Farrukh Aqil Research Topics

Disease

28	Neoplasms (Cancer) 11/2022 - 05/2011
7	Lung Neoplasms (Lung Cancer) 07/2021 - 08/2012
6	Breast Neoplasms (Breast Cancer) 03/2022 - 05/2011
6	Carcinogenesis 06/2021 - 11/2011
5	Neoplasm Metastasis (Metastasis) 12/2021 - 05/2011
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 12/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2017 - 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 11/2022
1	Triple Negative Breast Neoplasms 12/2021
1	Infections 12/2017
1	Uterine Cervical Dysplasia 12/2017
1	Cicatrix (Scar) 12/2017
1	Pathologic Constriction (Stenosis) 12/2017
1	Hemorrhage 12/2017
1	Infertility (Sterility) 12/2017
1	Ovarian Neoplasms (Ovarian Cancer) 11/2017
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Prolactinoma (Prolactinomas) 01/2016
1	Foreign Bodies (Foreign Body) 08/2011
1	Hemolysis 01/2007

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 03/2022 - 02/2016
6	Estrogens (Estrogen)FDA Link 01/2016 - 11/2011
5	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 11/2017
5	withaferin AIBA 04/2020 - 08/2012
4	Proteins (Proteins, Gene)FDA Link 11/2022 - 10/2013
4	Anthocyanins (Anthocyanin)IBA 12/2021 - 12/2012
4	MicroRNAs (MicroRNA)IBA 08/2016 - 10/2013
3	Folic Acid (Vitamin M)FDA LinkGeneric 07/2021 - 02/2016
3	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2019
3	CurcuminIBA 11/2017 - 08/2011
3	Ellagic AcidIBA 10/2013 - 11/2011
2	PhytochemicalsIBA 01/2022 - 01/2015
2	LigandsIBA 07/2021 - 02/2016
2	PowdersIBA 06/2021 - 06/2012
2	AntioxidantsIBA 04/2017 - 01/2013
1	Immunotoxins (Immunotoxin)IBA 11/2022
1	EnzymesIBA 11/2022
1	Albumin-Bound Paclitaxel FDA Link 07/2021
1	SolventsIBA 07/2021
1	taxaneIBA 04/2020
1	Dihydrotachysterol (AT 10)IBA 04/2020
1	PlatinumIBA 04/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2019
1	Subfamily B ATP Binding Cassette TransporterIBA 11/2017
1	Cisplatin (Platino)FDA LinkGeneric 11/2017
1	ClathrinIBA 11/2017
1	Anti-Infective Agents (Microbicides)IBA 01/2017
1	Conditioned Culture MediaIBA 08/2016
1	Biomarkers (Surrogate Marker)IBA 08/2016
1	Estrogen Receptor alphaIBA 01/2016
1	celastrolIBA 01/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2016
1	ProlactinIBA 01/2016
1	TriterpenesIBA 01/2016
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2015
1	tanshinoneIBA 01/2015
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 05/2014
1	PolyphenolsIBA 05/2014
1	Guanosine Triphosphate (GTP)IBA 03/2014
1	Cyclin G1IBA 10/2013
1	Cyclin D1IBA 10/2013
1	Estrogen ReceptorsIBA 10/2013
1	cucurbitacin BIBA 05/2013
1	Antineoplastic Agents (Antineoplastics)IBA 05/2013
1	Sulfhydryl Compounds (Thiols)IBA 05/2013
1	Biological ProductsIBA 05/2013
1	salicylhydroxamic acid (SHAM)IBA 08/2011
1	Phosphotransferases (Kinase)IBA 05/2011
1	Tyrosine (L-Tyrosine)FDA Link 05/2011
1	ErbB Receptors (EGF Receptor)IBA 05/2011
1	Insulin-Like PeptidesIBA 05/2011
1	Lapatinib (GW572016)FDA Link 05/2011
1	Trastuzumab (Herceptin)FDA Link 05/2011
1	Matrix Metalloproteinases (MMPs)IBA 05/2011
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2011
1	Bevacizumab (Avastin)FDA Link 05/2011
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2011
1	human ERBB2 proteinIBA 05/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2011
1	Plant ExtractsIBA 01/2007

Therapy/Procedure

6	Therapeutics 11/2022 - 05/2011
6	Chemoprevention 01/2022 - 08/2011
1	Combination Drug Therapy (Combination Chemotherapy) 04/2020
1	Operative Surgical Procedures 12/2017
1	Drug Therapy (Chemotherapy) 11/2017
1	Molecular Targeted Therapy 05/2011